Hematologic Malignancy
Prefibrotic Primary Myelofibrosis
CI-CAN-00008289Explore in graph →
Hematologic3 active trials
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00008289Explore in graph →
Clinical trials
8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03862157 | Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | active not recruiting | Phase 1 / Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT05198960 | AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms(AVAJAK) | recruiting | Phase 3 | 1,308 | University Hospital, BrestOTHER | 1 | Mar 20, 2026 |
| clinicaltrials |
| NCT04942080 | Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)(CALRSUIVI) | recruiting | N/A | 260 | University Hospital, AngersOTHER_GOV | 1 | Mar 6, 2026 | clinicaltrials |
| NCT03869476 | Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.(BioScoreSMP) | completed | N/A | 133 | University Hospital, AngersOTHER_GOV | 1 | Dec 30, 2024 | clinicaltrials |
| NCT06371573 | Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms | completed | — | 45 | Federico II UniversityOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05882773 | Asian Myeloproliferative Neoplasm (MPN) Registry | recruiting | — | 1,000 | The University of Hong KongOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT03121599 | 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms | terminated | N/A | 3 | Hamad Medical CorporationINDUSTRY | 1 | Aug 11, 2020 | clinicaltrials |
| NCT02528877 | Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis | withdrawn | Phase 1 | 0 | City of Hope Medical CenterOTHER | 1 | Sep 14, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Jul 16, 2026source: clinicaltrials